Effect of bilirubin in ischemia/reperfusion injury on rat small intestine.

PURPOSE The aim of this study was to determine the effects of bilirubin in experimental small intestinal ischemia/reperfusion (I/R) injury in rats. METHODS Thirty rats were divided into 5 groups (n = 6). In group S, saline and in group B, bilirubin, 20 mg/kg were infused via the jugular vein without an additional procedure. In groups S-IR, saline, B(1)-IR and B(2)-IR, 10 and 20 mg/kg/h of bilirubin were infused for 2 hours, respectively. In these groups, an I/R procedure was done after infusions by occluding the superior mesenteric artery for 45 minutes followed by 1 hour of reperfusion. After reperfusion, the small intestines were resected for histopathologic and malondialdehyde (MDA) assessments. Mucosal lesions were scored between 0 and 5. Malondialdehyde levels and histopathologic grades were analyzed statistically. RESULTS Mucosal injury was severe in S-IR (grade 4 to 5), mild in B(1)-IR (grade 0 to 3) and none in B(2)-IR group (grade 0). Grades of group S-IR were higher than those of B(1)-IR and B(2)-IR statistically (P <.05). Tissue MDA levels of the S-IR group were significantly higher than those of B(1)-IR and B(2)-IR groups (U = 36, P <.05). Bilirubin levels correlated inversely with MDA levels (r = -0.94). CONCLUSIONS Bilirubin effectively prevents intestinal I/R injury in rat. This observation is consistent with the hypotheses regarding bilirubin as an antioxidant, having a role in the body defense. J Pediatr Surg 36:1764-1767.

[1]  S. Suita,et al.  The relationship between the adenine nucleotide metabolism and the conversion of the xanthine oxidase enzyme system in ischemia-reperfusion of the rat small intestine. , 1996, Journal of pediatric surgery.

[2]  D. Menon,et al.  Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. , 1996, Critical care medicine.

[3]  M. Tanaka,et al.  Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. , 1996, Biochemical and biophysical research communications.

[4]  C. Rice-Evans,et al.  Bilirubin and ascorbate antioxidant activity in neonatal plasma , 1994, FEBS letters.

[5]  T. Kinoshita,et al.  A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. , 1993, Biochimica et biophysica acta.

[6]  D. Benaron,et al.  Variation of initial serum bilirubin rise in newborn infants with type of illness , 1991, The Lancet.

[7]  M. Ziegler,et al.  The role of reperfusion injury in occlusive intestinal ischemia of the neonate: malonaldehyde-derived fluorescent products and correlation of histology. , 1991, The Journal of surgical research.

[8]  B. Halliwell,et al.  The antioxidants of human extracellular fluids. , 1990, Archives of biochemistry and biophysics.

[9]  A. Mcdonagh,et al.  Is bilirubin good for you? , 1990, Clinics in perinatology.

[10]  T. Otamiri Oxygen radicals, lipid peroxidation, and neutrophil infiltration after small-intestinal ischemia and reperfusion. , 1989, Surgery.

[11]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[12]  K. Tan,et al.  Phototherapy for neonatal jaundice in infants with intestinal obstruction. , 1983, The Journal of pediatrics.

[13]  D. Granger,et al.  Role of oxygen radicals in the pathogenesis of intestinal ischemia. , 1983, The Physiologist.

[14]  M. Uchiyama,et al.  Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. , 1978, Analytical biochemistry.

[15]  A. Entress,et al.  Letter: Continuous positive airways pressure in infants. , 1974, Lancet.

[16]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.

[17]  Najib-Farah DEFENSIVE ROLE OF BILIRUBINÆMIA IN PNEUMOCOCCAL INFECTION , 1937 .

[18]  P. Chessex,et al.  Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. , 1997, Biology of the neonate.

[19]  K. Fung,et al.  Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. , 1994, Life sciences.

[20]  R. Mayer,et al.  Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. , 1993, The Journal of pharmacology and experimental therapeutics.

[21]  G. Ritzel,et al.  Über eine biologische Bedeutung der Gallenfarbstoffe. Bilirubin und Biliverdin als Antioxydantien für das Vitamin A und die essentiellen Fettsäuren , 1954 .